Empowering drug discovery by enhancing capabilities
We empower drug discovery by significantly enhancing our client capabilities:
- Accelerating Discovery: Our solutions streamline research processes, enabling faster identification of promising drug candidates.
- Scaling Capacity: We help clients expand their project portfolio to meet the demands of new partnerships and collaborations.
- Minimizing Data Burden: Our tools automate and streamline data management, freeing scientists to focus on core research activities.
Through a combination of technical expertise, innovative software development, and strategic system integrations, we have enabled our clients to achieve remarkable results, including:
- Identification of Druggable Genes: Unlocking new therapeutic targets.
- Elimination of Backlogs: Clearing obstacles to progress.
- Discovery of Overlooked Candidates: Revealing hidden potential in existing data.
We are committed to removing barriers to innovation and empowering our clients to make groundbreaking discoveries in drug development.
Recent Projects
Research Management System
Developed a web application to integrate target management, protein target construct designs, clone/protein/compound order management, DEL library management, registration, and inventory into a single system.
Medium Biopharmaceutical Company
Diagnostics LIMS System
Designed a custom system to integrate order management, EMRs, sample management, report management, inventory, kit management, customer management (Salesforce), billing management (XIFIN), and appointment scheduling (WorkPath).
Small Diagnostics Company
Microservices & Web Components
Developed a foundation for a large antibody drug discovery lab using microservices and web components to provide flexibility and scalability.
Results: Company used the foundation to create a new antibody drug discovery platform.
Large Pharmaceutical Company
Technology Roadmap
Helped a cell-based therapeutics startup identify solutions to support their therapeutic discovery operations and provided an unbiased set of recommendations for a new cloud-based ELN/LIMS system.
Results: Customer used the system to collect data for their first therapeutic candidate.
Drug Discovery Company
QualFX: Kinase Profiling App
Created a desktop application for a drug discovery company that allowed scientists to analyze and store kinase profiling data for a targeted drug discovery platform.
Results: Company was able to use the system to review historic data and identify a new drug candidate that had been previously overlooked.
Small Drug Discovery Company
Compound Management
Studied current methods in use, designed and developed a new system that chemists use to accelerate and track ordering, plating, and shipping of compounds for screening.
Results: Cleared a backlog of over 200 issues with the system, and created a steering group to prioritize new development efforts. Integrated system with liquid handler to improve throughput.
Large Pharmaceutical Company
Protein-Protein Interaction Mining System
Developed a web-based text-mining system for the purpose of identifying protein-protein interactions from PubMed data.
Dana Farber Cancer Institute
Project Pipeline
An application created to manage the pharmaceutical project portfolio, with tools to track target information, tasks, meetings, risks, issues, and documents.
Large Pharmaceutical Company
Project Reporting System
Designed and implemented a project reporting system specifically for scientists to ease and accelerate the generation of quarterly reports on drug discovery projects in the portfolio.
Large Drug Discovery Company
Phenotypic Assay Management System
Evaluated current methods in use and created a tailored web application specifically to collect and analyze data from 500 phenotypic assays used to support a large-scale drug target validation program.
Large Drug Discovery Company
Drug Target Management System
Designed and implemented a custom software system allowing scientists to prioritize and review drug targets for a large-scale target knockout program.
Results: This system was used to identify and prioritize the 5000 most druggable genes in the human genome.
Large Drug Discovery Company